Talis Biomedical Stock

Talis Biomedical EBIT Margin

Delisted

The EBIT Margin (Operating Margin) of Talis Biomedical (TLIS) as of Aug 1, 2026 is -2,999.77 %. In the previous year, EBIT Margin (Operating Margin) was -2,392.75 % — a change of 25.37% (lower).

EBIT Margin

-2,999.77 %

YoY

25.37%

Last updated:

EBIT Margin (Operating Margin) of Talis Biomedical is 2026 -2,999.77 % . EBIT Margin (Operating Margin) of Talis Biomedical was 2025 -2,392.75 % . It decreases by 25.37% lower compared to the previous year.

For Talis Biomedical, the operating (EBIT) margin of -2,999.8% is down versus -671.3% a few years ago.

Access this data via the Eulerpool API

Talis Biomedical Stock analysis

What does Talis Biomedical do? Talis Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Talis Biomedical stock

EBIT Margin (Operating Margin) of Talis Biomedical is -2,999.77 % in 2026.

Access this data via the Eulerpool API

Margins — Talis Biomedical

All Key Metrics — Talis Biomedical